Examining functional alterations of HIV-1 Tat variants associated with neurocognitively impaired patients in the Drexel Medicine CARES Cohort

Examining functional alterations of HIV-1 Tat variants associated with neurocognitively impaired patients in the Drexel Medicine CARES Cohort

Bibliographic Details
Main Authors:	M.R. Nonnemacher, A.R. Mele, K.M. King, G. Antell, W. Dampier, R. Tata, V. Pirrone, J. Williams, G. Homan, S. Passic, K. Kercher, W. Zhong, Z. Szep, J. Jacobson, B. Wigdahl, S. Kortagere
Format:	Article
Language:	English
Published:	Elsevier 2017-12-01
Series:	Journal of Virus Eradication
Online Access:	http://www.sciencedirect.com/science/article/pii/S2055664020306245

Similar Items

PP 1.43 – 00206 Evaluating integrated HIV-1 quasispecies using Near Full Length sequencing in ART-suppressed individuals in the Drexel CARES Cohort
by: M. Collins, et al.
Published: (2022-12-01)

HIV-1 Tat Length: Comparative and Functional Considerations
by: Anthony R. Mele, et al.
Published: (2020-03-01)

Utilizing the binding capacity of CRISPR/Cas9 to target the HIV-1 quasispecies
by: M. Nonnemacher, et al.
Published: (2015-12-01)

PP 6.5 – 00205 Utilization of high-throughput assays and deep-learning for selection of CRISPR/Cas9-gRNA pairs used in an HIV-1 cure strategy
by: R. Berman, et al.
Published: (2022-12-01)

Designing broad-spectrum gRNAs to target the HIV-1 LTR with CRISPR/cas9-based therapeutic strategies
by: A. Allen, et al.
Published: (2017-12-01)

Genetic variation continues to occur in well-controlled HIV-1-infected patients
by: W. Dampier, et al.
Published: (2015-12-01)

Extracellular HIV-1 Tat Mediates Increased Glutamate in the CNS Leading to Onset of Senescence and Progression of HAND
by: Jamie Marino, et al.
Published: (2020-06-01)

Interaction between Tat and Drugs of Abuse during HIV-1 Infection and Central Nervous System Disease
by: Monique E Maubert, et al.
Published: (2016-01-01)

HIV-1 Genetic Variation Resulting in the Development of New Quasispecies Continues to Be Encountered in the Peripheral Blood of Well-Suppressed Patients.
by: Will Dampier, et al.
Published: (2016-01-01)

Computational analysis of cas proteins unlocks new potential in HIV-1 targeted gene therapy
by: Will Dampier, et al.
Published: (2024-01-01)

SNPs within the HIV-1 LTR associate with increased virus persistence
by: N.T. Sullivan, et al.
Published: (2015-12-01)

Mitochondrial Haplogroup Influences Motor Function in Long-Term HIV-1-Infected Individuals.
by: Ashley Azar, et al.
Published: (2016-01-01)

Computational detection of off-target effects of CRISPR/Cas9-associated gRNAs
by: W. Dampier, et al.
Published: (2015-12-01)

HIV-Quasipore: A Suite of HIV-1-Specific Nanopore Basecallers Designed to Enhance Viral Quasispecies Detection
by: Robert W. Link, et al.
Published: (2022-05-01)

Gene Editing of HIV-1 Co-receptors to Prevent and/or Cure Virus Infection
by: Alexander G. Allen, et al.
Published: (2018-12-01)

Designing Safer CRISPR/Cas9 Therapeutics for HIV: Defining Factors That Regulate and Technologies Used to Detect Off-Target Editing
by: Neil T. Sullivan, et al.
Published: (2020-08-01)

Computational Design of gRNAs Targeting Genetic Variants Across HIV-1 Subtypes for CRISPR-Mediated Antiviral Therapy
by: Cheng-Han Chung, et al.
Published: (2021-03-01)

Broad-spectrum gRNAs abolish HIV-1 LTR-mediated transcription in cells that receive CRISPR/Cas9 therapy
by: B. Wigdahl, et al.
Published: (2019-12-01)

HIV- Bidirectional Encoder Representations From Transformers: A Set of Pretrained Transformers for Accelerating HIV Deep Learning Tasks
by: Will Dampier, et al.
Published: (2022-05-01)

CCAAT enhancer binding protein and nuclear factor of activated T cells regulate HIV-1 LTR via a novel conserved downstream site in cells of the monocyte-macrophage lineage.
by: Satinder Dahiya, et al.
Published: (2014-01-01)

Mild cognitive impairment in a clinically latent HIV-1 patient population
by: K.N. Devlin, et al.
Published: (2015-12-01)

Examining virtual driving test performance and its relationship to individuals with HIV-associated neurocognitive disorders
by: David Grethlein, et al.
Published: (2022-08-01)

Application and removal of polyanionic microbicide compounds enhances subsequent infection by HIV-1
by: Pirrone Vanessa, et al.
Published: (2012-01-01)

HIV-1 Promoter Single Nucleotide Polymorphisms Are Associated with Clinical Disease Severity.
by: Michael R Nonnemacher, et al.
Published: (2016-01-01)

Assessment of anti-HIV-1 guide RNA efficacy in cells containing the viral target sequence, corresponding gRNA, and CRISPR/Cas9
by: Alexander G. Allen, et al.
Published: (2023-04-01)

Let Him Use You: Southern Womanism, Utterance, and Saint Katharine Drexel's Educational Philosophy
by: Berlisha Roketa Morton
Published: (2022-02-01)

Morphine exposure exacerbates HIV-1 Tat driven changes to neuroinflammatory factors in cultured astrocytes.
by: Kenneth Chen, et al.
Published: (2020-01-01)

Off-Target Analysis in Gene Editing and Applications for Clinical Translation of CRISPR/Cas9 in HIV-1 Therapy
by: Andrew Atkins, et al.
Published: (2021-08-01)

Spanish normative studies in young adults (NEURONORMA young adults project): Norms for Stroop Color–Word Interference and Tower of London-Drexel University tests
by: T. Rognoni, et al.
Published: (2013-03-01)

Molecular Modeling of Subtype-Specific Tat Protein Signatures to Predict Tat-TAR Interactions That May Be Involved in HIV-Associated Neurocognitive Disorders
by: Monray E. Williams, et al.
Published: (2022-04-01)

Safe CRISPR-Cas9 Inhibition of HIV-1 with High Specificity and Broad-Spectrum Activity by Targeting LTR NF-κB Binding Sites
by: Cheng-Han Chung, et al.
Published: (2020-09-01)

Defining differential genetic signatures in CXCR4- and the CCR5-utilizing HIV-1 co-linear sequences.
by: Benjamas Aiamkitsumrit, et al.
Published: (2014-01-01)

Signatures of HIV-1 subtype B and C Tat proteins and their effects in the neuropathogenesis of HIV-associated neurocognitive impairments
by: Monray E. Williams, et al.
Published: (2020-03-01)

CRISPR/Cas9 editing of HIV-1 transcription factor binding sites on the 5’ long terminal repeats to permanently inactivate latent provirus
by: B. Wigdahl, et al.
Published: (2019-12-01)

cAMP Signaling Enhances HIV-1 Long Terminal Repeat (LTR)-directed Transcription and Viral Replication in Bone Marrow Progenitor Cells
by: Anupam Banerjee, et al.
Published: (2017-03-01)

Opinion: Inhibition of Blood-Brain Barrier Repair as a Mechanism in HIV-1 Disease
by: Michael R. Nonnemacher, et al.
Published: (2017-04-01)

Role of FOXO3 Activated by HIV-1 Tat in HIV-Associated Neurocognitive Disorder Neuronal Apoptosis
by: Huaqian Dong, et al.
Published: (2019-02-01)

Time-dependent, HIV-Tat-induced perturbation of human neurons in vitro: towards a model for the molecular pathology of HIV-associated neurocognitive disorders
by: Gurwitz, K, et al.
Published: (2017)

Estudios normativos españoles en población adulta joven (proyecto NEURONORMA jóvenes): normas para las pruebas Stroop Color-Word Interference Test y Tower of London-Drexel University
by: T. Rognoni, et al.
Published: (2013-03-01)

Cellular phenotype impacts human immunodeficiency virus type 1 viral protein R subcellular localization
by: Ferrucci Adriano, et al.
Published: (2011-08-01)